Angiocrine Bioscience, Inc.
- UEI
- F6V8JNZZG6E6
- CAGE
- 77BV8
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Website
- angiocrinebioscience.com
- Founded
- 2012
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| "sbir phase i large scale propagation of cancer cells using the veravec platform in an automated closed system" | National Cancer Institute (NIH) | $189,094 |
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of an automated umbilical cord blood hematopoietic stem cell expansion by endothelial cells for… | National Institutes of Health | $161,000 |
Quick answers
Is Angiocrine Bioscience, Inc. registered in SAM.gov?
Angiocrine Bioscience, Inc.'s SAM.gov registration expired on May 31, 2025.
What is Angiocrine Bioscience, Inc.'s most recent federal award?
Angiocrine Bioscience, Inc.'s most recent federal contract award is "sbir phase i large scale propagation of cancer cells using the veravec platform in an automated closed system" (HHSN261201500064C), from National Cancer Institute (NIH), on September 22, 2015.
On GovTribe
See Angiocrine Bioscience, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors